Mersana Therapeutics Inc (MRSN)
2.33
-0.07
(-2.92%)
USD |
NASDAQ |
May 31, 16:00
2.335
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Total Long Term Debt (Quarterly): 25.31M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 25.31M |
December 31, 2023 | 25.23M |
September 30, 2023 | 25.16M |
June 30, 2023 | 25.08M |
March 31, 2023 | 25.00M |
December 31, 2022 | 24.93M |
September 30, 2022 | 24.85M |
June 30, 2022 | 24.78M |
March 31, 2022 | 24.70M |
December 31, 2021 | 24.63M |
September 30, 2021 | 5.077M |
June 30, 2021 | 5.043M |
March 31, 2021 | 5.01M |
December 31, 2020 | 4.977M |
September 30, 2020 | 4.944M |
June 30, 2020 | 4.93M |
March 31, 2020 | 4.899M |
Date | Value |
---|---|
December 31, 2019 | 4.868M |
September 30, 2019 | 4.837M |
June 30, 2019 | 4.805M |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
4.805M
Minimum
Jun 2019
25.31M
Maximum
Mar 2024
14.95M
Average
14.85M
Median
Total Long Term Debt (Quarterly) Benchmarks
Amicus Therapeutics Inc | 388.39M |
Insmed Inc | 1.163B |
Altimmune Inc | 0.00 |
InfuSystems Holdings Inc | 29.93M |
Anavex Life Sciences Corp | -- |